Cargando…

Bioinformatics analysis of BIRC5 in human cancers

BACKGROUND: An inhibitor of apoptosis (IAP) family member, baculoviral IAP repeat containing five (BIRC5) plays an important role in the occurrence and development of tumors. However, the underlying mechanism in human cancers remains unclear. METHODS: In this study, we investigated BIRC5 expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Han-Bin, Ma, Bao-Jun, Meng, Gao-Qiang, Tao, Shuo, Wang, Yong, Chen, Zhenghua, Zhao, Wei, Ren, Bing-Yan, Ye, Zi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469138/ https://www.ncbi.nlm.nih.gov/pubmed/36111008 http://dx.doi.org/10.21037/atm-22-3496

Ejemplares similares

Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis
por: Dai, Jian-bo, et al.
Publicado: (2020)

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)

Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma
por: Troiano, Giuseppe, et al.
Publicado: (2018)

Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer
por: Ye, Leiguang, et al.
Publicado: (2015)

Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis
por: Cao, Yajuan, et al.
Publicado: (2019)

Scutellarin inhibits the glioma cell proliferation by downregulating BIRC5 to promote cell apoptosis
por: Wang, Feng, et al.
Publicado: (2023)

Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells
por: Thorne, Andrew, et al.
Publicado: (2023)

Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton's Jelly (WJSC) in Younger Women Giving Birth Naturally
por: Gil-Kulik, Paulina, et al.
Publicado: (2020)

Identification of CDCA8, DSN1 and BIRC5 in Regulating Cell Cycle and Apoptosis in Osteosarcoma Using Bioinformatics and Cell Biology
por: Li, Qinwen, et al.
Publicado: (2020)

BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response
por: Xu, Haiting, et al.
Publicado: (2022)

hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression
por: Peng, Wei-zhao, et al.
Publicado: (2021)

BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration
por: Xu, Linlong, et al.
Publicado: (2021)

Long non-coding RNA SNHG3 promotes the progression of clear cell renal cell carcinoma via regulating BIRC5 expression
por: Xu, Zhaoyu, et al.
Publicado: (2021)

Gene Network Revealed Involvements of Birc2, Birc3 and Tnfrsf1a in Anti-Apoptosis of Injured Peripheral Nerves
por: Wang, Yongjun, et al.
Publicado: (2012)

BIRC5/Survivin Expression as a Non-Invasive Biomarker of Endometriosis
por: Filipchiuk, Carolina, et al.
Publicado: (2020)

BIRC5 Expression Is Regulated in Uterine Epithelium during the Estrous Cycle
por: Cho, Minha, et al.
Publicado: (2020)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022)

BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
por: Ma, Teng, et al.
Publicado: (2022)

Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor-κB-activating potential
por: Yamato, Azusa, et al.
Publicado: (2015)

Association of BIRC5 Gene Polymorphism with the Collateral Circulation and Severity of Large Artery Atherosclerotic Stroke
por: Huang, Jianmin, et al.
Publicado: (2022)

Potential Involvement of BIRC5 in Maintaining Pluripotency and Cell Differentiation of Human Stem Cells
por: Gil-Kulik, Paulina, et al.
Publicado: (2019)

TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5
por: Wu, Mengqiu, et al.
Publicado: (2023)

Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
por: Xu, Rongzhong, et al.
Publicado: (2021)

BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer
por: Ghaffari, Kimia, et al.
Publicado: (2016)

Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma
por: Mika, Aleksander, et al.
Publicado: (2019)

Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2019)

Fe(3)O(4) magnetic nanoparticle-enhanced radiotherapy for lung adenocarcinoma via delivery of siBIRC5 and AS-ODN
por: Chen, Shuzhen, et al.
Publicado: (2021)

Expression Profiles Reveal Involvement of VEGF, IGF1, BIRC5, and MMP1 in Vulvar Carcinogenesis
por: Zhang, Tao, et al.
Publicado: (2021)

DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5
por: Wang, Liang, et al.
Publicado: (2021)

Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells
por: Zhao, Guannan, et al.
Publicado: (2017)

Inhibition of BIRC2 Sensitizes α7-HPV-Related Cervical Squamous Cell Carcinoma to Chemotherapy
por: Lin, Chiao-Yun, et al.
Publicado: (2021)

Identification and Validation of Afatinib Potential Drug Resistance Gene BIRC5 in Non-Small Cell Lung Cancer
por: Zhu, Xiaoxi, et al.
Publicado: (2021)

miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5
por: Meng, Xin, et al.
Publicado: (2021)

BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma
por: Cao, Lu, et al.
Publicado: (2013)

Polymorphisms in Survivin (BIRC5 Gene) Are Associated with Age of Onset in Breast Cancer Patients
por: Sušac, Ilona, et al.
Publicado: (2019)

BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma
por: Wang, Nan, et al.
Publicado: (2022)

miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
por: Yuan, Chao, et al.
Publicado: (2021)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2022)

miR‐92a‐3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis
por: Yu, Zhi‐Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_82k4s941a1abn80n39207p4nub